Free testosterone measures the small unbound fraction of circulating testosterone not attached to SHBG or albumin. Learn what the test captures, how results are generated, and where clinical guidance actually applies.
Dozens of common medications can falsely raise or lower FSH results. Learn which drugs interfere with follicle-stimulating hormone testing and how to get accurate readings.
FSH (follicle-stimulating hormone) blood test explained: what it measures, normal ranges by age and sex, what high or low results mean, and how clinicians use FSH to evaluate fertility, menopause, and pituitary function.
Learn what galectin-3 levels mean for heart failure prognosis, fibrosis risk, and medication decisions. Covers normal ranges, high and low values, and evidence-based ways to lower galectin-3.
Galectin-3 is a blood biomarker linked to tissue fibrosis and heart failure prognosis. This article explains what the test measures, how results are interpreted, and where the evidence is solid versus preliminary.
Medications, supplements, and substances that interfere with urinary organic acids testing. Learn which drugs to pause, for how long, and why specific metabolite markers shift.
Learn what organic acids urine testing measures, how conventional reference ranges differ from functional optimal levels, and what abnormal results mean for your metabolic health.
An organic acid profile can't stand alone. Pair it with plasma amino acids, acylcarnitines, MMA, and homocysteine for accurate interpretation.
Standard GGT normal range is 8-65 U/L for men and 5-45 U/L for women, but optimal levels linked to lower cardiovascular risk are 9-25 U/L for both sexes.
Glucocorticoids, opioids, oral estrogens, antipsychotics, dopamine agonists, and body fat can each blunt or exaggerate the growth hormone peak on a stimulation test. What to hold, what cannot be held, and how to interpret a result when a confounder is unavoidable.
Learn what your ghrelin blood test means, including normal ranges, high and low levels, connections to GLP-1 therapy and bariatric surgery, and evidence-based strategies for managing ghrelin.
A clinical guide to ordering ghrelin blood tests, including indications, normal ranges, interpretation of high and low levels, and how ghrelin relates to GLP-1 therapy and metabolic health.
What your GLP-1 (active) lab value actually means, how reference ranges differ from functional targets, and when levels signal a clinical problem.
A clinical guide to the lab panels that should accompany a GLP-1 (active) assay, including insulin, C-peptide, HbA1c, lipids, and hepatic markers, with evidence-based rationale for each pairing.
A clinical breakdown of the GLP-1 (active) blood test, including what it measures, normal reference ranges, how to interpret high or low results, and when clinicians order it.
Complete guide to medications that falsely lower or raise 1,5-anhydroglucitol (GlycoMark) results, including SGLT2 inhibitors, acarbose, and dapagliflozin. Learn how to interpret results on these drugs.
How a GlycoMark (1,5-AG) result fits into diabetes monitoring alongside HbA1c, when the test is not reliable, and what a low or high result should prompt you to ask your clinician. Pending qualified medical review.
Learn which lab tests to pair with GlycoMark (1,5-AG) to detect postprandial glucose spikes, track long-term control, and guide therapy adjustments in diabetes management.
Standard HbA1c reference ranges label 5.6% as normal, but functional medicine targets 4.8 to 5.2% for metabolic optimization. Learn what the numbers mean, how guidelines differ, and when to act.
A guide to medications that raise or lower hematocrit, including testosterone, EPO, GLP-1 agonists, chemotherapy, and antiretrovirals. Learn normal ranges, clinical thresholds, and when to recheck.
Your hematocrit level directly influences testosterone therapy dosing, GLP-1 eligibility, and clinical safety decisions. Learn the ranges, risks, and protocol adjustments tied to your number.
A guide to raising or lowering hematocrit safely, covering hydration, phlebotomy, iron optimization, testosterone therapy monitoring, and when to act on abnormal CBC results.
A low hematocrit result explained: causes like blood loss, anemia, or hydration effects, how it compares to reference ranges, and when it signals a real problem.
Your hematocrit may fall inside the standard lab reference range without being at the level clinicians consider optimal for cardiovascular risk. What the ranges mean, what drives high and low results, and when a value needs action rather than reassurance.
Common medications that artificially raise or lower HOMA-IR scores, how to interpret results on these drugs, and when to retest for accurate insulin resistance assessment.
Learn what HOMA-IR measures, how standard reference ranges differ from functional optimal targets, and evidence-based strategies to improve insulin sensitivity.
Learn when clinicians should order a HOMA-IR test, what normal ranges look like, how to interpret high or low scores, and evidence-based strategies for improving insulin resistance.
Learn what your homocysteine blood test result means, what normal ranges look like, and what elevated or low levels signal about your cardiovascular and methylation health.
A clinical guide to the homocysteine blood test, including what it measures, normal ranges, causes of high and low levels, and evidence-based strategies to optimize your result.
Learn when clinicians order a homocysteine blood test, what normal levels look like, and how elevated homocysteine connects to cardiovascular risk, B-vitamin deficiency, and methylation status.
A guide to raising HRV through exercise, sleep, breathing protocols, nutrition, and stress management, with specific studies and dosing.
Shaffer and Ginsberg's HRV norms show RMSSD 15-100+ms; optimal is upper-quartile, 40-100ms under 50. See age-matched SDNN and RMSSD targets explained.
A guide to the lab tests and biomarkers you should pair with HRV monitoring for a complete picture of autonomic, metabolic, and cardiovascular health.
A guide to lowering high-sensitivity C-reactive protein (hs-CRP) through exercise, diet, weight loss, statins, and targeted interventions, with specific trial data and dose ranges.
Learn what your hs-CRP level means, how to read low, average, and high-risk ranges, and what steps are supported by evidence for lowering chronic inflammation tied to cardiovascular and metabolic disease.
hs-CRP measures low-level systemic inflammation using a high-sensitivity assay. Learn what normal ranges mean, how hs-CRP predicts cardiovascular risk, and what drives levels up or down.
A clinical guide to medications and substances that can falsely raise or suppress high-sensitivity troponin (hs-cTn) levels, how to interpret results on these drugs, and when retesting is warranted.
Learn how hs-troponin levels guide clinical decisions, from ruling out heart attacks to adjusting medications. Includes normal ranges, causes of elevation, and treatment implications.
A clinician-reviewed guide to understanding hs-troponin levels, normal ranges, what elevated or low values mean, and when to act on your result.
How to interpret high-sensitivity troponin using the assay, reference limit, symptoms, ECG, and repeat results, and what normal or optimal really means.
Learn how your IGF-1 level directly shapes GH peptide therapy, dosing adjustments, and clinical decisions. Includes normal ranges, high and low IGF-1 interpretation, and monitoring protocols.
Learn what your IGF-1 blood test means, what normal ranges look like by age, and what high or low levels signal about growth hormone status, longevity risk, and peptide therapy.
Learn when clinicians order IGF-1 blood tests, what normal ranges look like by age, and how to interpret high or low results in the context of growth hormone therapy, peptide protocols, and longevity medicine.
Learn what IGFBP-3 is, what normal ranges look like, and the clinically supported strategies to raise or lower your IGFBP-3 levels through nutrition, exercise, sleep, and medical intervention.
Learn the difference between standard IGFBP-3 reference ranges and functional optimal levels. Understand what your IGFBP-3 result means for GH axis health, when to act, and how clinicians interpret this biomarker alongside IGF-1.
Learn when clinicians order IGFBP-3, what normal ranges look like across age groups, and how results guide growth hormone axis evaluation.
A clinical breakdown of the iron, TIBC, and transferrin saturation panel. Learn what each marker tells your doctor, how to interpret your results, and when abnormal values signal deficiency or overload.
Dozens of common medications can raise or lower serum leptin independently of body fat. Learn which drugs distort leptin lab results, by how much, and how to time your blood draw for accurate readings.
A clinical guide to leptin testing, including what the hormone does, normal reference ranges by sex, what high and low results mean, and how leptin connects to obesity, GLP-1 therapy, and metabolic health.
Learn when clinicians order a serum leptin test, what normal leptin levels look like, how to interpret high or low results, and how leptin connects to obesity, GLP-1 therapy, and metabolic health.
A clinical guide to the tests you should pair with luteinizing hormone (LH) to accurately diagnose hypogonadism, PCOS, infertility, and pituitary disorders.
A clinical breakdown of how each lipid panel value (LDL-C, HDL-C, triglycerides, total cholesterol) directly shapes statin therapy, add-on medications, and lifestyle prescriptions.
Learn what each number on your lipid panel means, what normal ranges look like, and when your results signal cardiovascular risk that requires treatment.
A clinical breakdown of every marker on a standard lipid panel, what the numbers mean, how they predict cardiovascular risk, and when to retest.
Learn when to order a standard lipid panel, what the results mean, normal ranges for total cholesterol, LDL, HDL, and triglycerides, and how screening frequency changes with age and risk factors.
A clinical guide to lipoprotein(a), what your Lp(a) level means, and every evidence-based strategy available to lower it, including emerging therapies, lifestyle factors, and FDA-tracked antisense drugs.
Learn what your Lp(a) blood test result means, what counts as a normal range, what elevated Lp(a) signals for cardiovascular risk, and which treatments are on the horizon.
Lp(a) is a genetically influenced lipoprotein that is being studied as an independent contributor to cardiovascular risk. Learn what the test measures, how thresholds are used, and where the evidence is still developing.
Learn when clinicians should order lipoprotein(a) testing, what Lp(a) levels mean, normal ranges, and evidence-based strategies for managing elevated Lp(a) cardiovascular risk.
Learn how your LP-IR score from NMR LipoProfile testing guides medication choices, lifestyle interventions, and metabolic treatment decisions for insulin resistance.